Elicio Therapeutics Statistics
NASDAQ: ELTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.83-0.025 (-1.36%)
Market open · Delayed 15 min · as of Oct 8, 2:35 PM ET
Elicio Therapeutics by the numbers
Elicio Therapeutics has a market capitalization of $48.0 million based on 26.28M shares outstanding. With trailing EPS of $-2.16, Elicio Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.0% below its 50-day average and 75.0% below its 200-day average.
Average daily trading volume is 352.93K shares, or about $644,088 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELTX valuation vs. peer median
| Metric | ELTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $47.96M | $49.52M | -3% |
| Avg. volume | 352.93K | 392.66K | -10% |
Peer median across 8 companies: ANVS, CRVO, DWTX, HYPD, EDSA, SER, CELU, HOWL.
Valuation
- Market cap
- $47.96M
- EPS (TTM)
- $-2.16
- Shares outstanding
- 26.28M
Price and trading
- Previous close
- 1.85
- Open
- 1.85
- Day range
- 1.74 – 1.85
- 52-week range
- 1.71 – 16.00
- 52-week change
- -82.85%
- Beta
- —
- Volume
- 101.67K
- Average volume
- 352.93K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 47.96M
- Forward Pe
- -1.08
- Eps
- -2.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.00
- Week52 Low
- 1.71
- Avg Volume
- 352.93K
- Shares Outstanding
- 26.28M
- Ma50
- 2.50
- Ma200
- 7.31
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -88.59%
- Pct From52w Low
- 7.04%